sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has released a Form 8.3 disclosure regarding its stake in Spire Healthcare Group plc. As of December 5, 2025, Vanguard held 14,400,487 ordinary shares, representing a 3.58% interest in Spire Healthcare. This disclosure aligns with Rule 8.3 of the Takeover Code, addressing positions of those with over 1% stakes in relevant securities.
The document highlights Vanguard's recent activity, including a purchase of 7,002 shares at a price of 1.76 GBP per share. No derivative positions or arrangements are reported, and no additional disclosures were made regarding other dealings or agreements on securities relating to Spire Healthcare.
The disclosure, dated December 8, 2025, includes no commitments such as indemnities or stock-settled derivatives, ensuring transparency as required by the Code. Contact for further information is Shawn Acker at Vanguard.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.